0001179110-18-006498.txt : 20180509 0001179110-18-006498.hdr.sgml : 20180509 20180509191755 ACCESSION NUMBER: 0001179110-18-006498 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180507 FILED AS OF DATE: 20180509 DATE AS OF CHANGE: 20180509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PUHY DOROTHY E CENTRAL INDEX KEY: 0001200493 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09585 FILM NUMBER: 18820070 MAIL ADDRESS: STREET 1: DANA FARBER CANCER INSTITUTE STREET 2: 44 BINNEY STREET, RM. D1632 CITY: BOSTON STATE: MA ZIP: 02115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABIOMED INC CENTRAL INDEX KEY: 0000815094 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042743260 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 22 CHERRY HILL DR CITY: DANVERS STATE: MA ZIP: 01923 BUSINESS PHONE: 9787775410 MAIL ADDRESS: STREET 1: 22 CHERRY HILL DRIVE CITY: DANVERS STATE: MA ZIP: 01923 4 1 edgar.xml FORM 4 - X0306 4 2018-05-07 0 0000815094 ABIOMED INC ABMD 0001200493 PUHY DOROTHY E C/O ABIOMED, INC. 22 CHERRY HILL DRIVE DANVERS MA 01923 1 0 0 0 Common Stock, $0.01 par value 2018-05-07 4 M 0 13500 9.99 A 46668 D Common Stock, $0.01 par value 2018-05-07 4 S 0 1229 345.1036 D 45439 D Common Stock, $0.01 par value 2018-05-07 4 S 0 1664 346.2000 D 43775 D Common Stock, $0.01 par value 2018-05-07 4 S 0 3012 347.0675 D 40763 D Common Stock, $0.01 par value 2018-05-07 4 S 0 1500 348.0720 D 39263 D Common Stock, $0.01 par value 2018-05-07 4 S 0 4195 349.0706 D 35068 D Common Stock, $0.01 par value 2018-05-07 4 S 0 700 349.9800 D 34368 D Common Stock, $0.01 par value 2018-05-07 4 S 0 900 351.0589 D 33468 D Common Stock, $0.01 par value 2018-05-07 4 S 0 300 351.9700 D 33168 D Common Stock, $0.01 par value 2017-11-09 5 G 0 E 11335 0 D 21833 D Common Stock, $0.01 par value 2017-11-09 5 G 0 E 11335 0 A 11335 I By Trust Stock Option (right to buy) 9.99 2018-05-07 4 M 0 13500 0 D 2011-08-10 2020-08-11 Common Stock 13500 0 D Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan. This option becomes exerciseable in full on the date set forth in Table II, Column 6. Exercise of stock options pursuant to reporting owner's 10b5-1 plan. Sale of common stock pursuant to reporting owner's 10b5-1 plan. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $344.5600 and $345.4900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $345.6500 and $346.3800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $346.6000 and $347.4600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $347.8400 and $348.4800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $348.5600 and $349.4000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $349.7900 and $350.4100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $350.9600 and $351.2300. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust. /s/ Stephen C. McEvoy (by power of attorney) 2018-05-09 EX-24 2 ex24puhy.txt LIMITED POWER OF ATTORNEY The undersigned does hereby appoint each of Stephen McEvoy, Ian McLeod, Michael Dube and Linda Day, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as a director or officer of ABIOMED, Inc. (the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in- fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, this power of attorney has been executed as of the 3rd day of July, 2009 and shall remain in full force and effect until withdrawn by the undersigned in writing. Signature: /s/ Dorothy E. Puhy Print Name: Dorothy E. Puhy - 2 -